+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Axillary Hyperhidrosis - Pipeline Insight, 2024 - Product Thumbnail Image

Axillary Hyperhidrosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Uremic Pruritus - Pipeline Insight, 2024 - Product Thumbnail Image

Uremic Pruritus - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Schnitzler syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Schnitzler syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Recessive Dystrophic Epidermolysis (RDEB) - Pipeline Insight, 2024 - Product Thumbnail Image

Recessive Dystrophic Epidermolysis (RDEB) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Pyoderma gangrenosum - Pipeline Insight, 2024 - Product Thumbnail Image

Pyoderma gangrenosum - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Pruritis - Pipeline Insight, 2024 - Product Thumbnail Image

Pruritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Ichthyosis - Pipeline Insight, 2024 - Product Thumbnail Image

Ichthyosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Glabellar Lines - Pipeline Insight, 2024 - Product Thumbnail Image

Glabellar Lines - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
Xerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Xerosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Severe Acne Vulgaris - Pipeline Insight, 2024 - Product Thumbnail Image

Severe Acne Vulgaris - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 70 Pages
  • Global
From
Eczema - Pipeline Insight, 2024 - Product Thumbnail Image

Eczema - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Acne - Pipeline Insight, 2024 - Product Thumbnail Image

Acne - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Bunion - Pipeline Insight, 2024 - Product Thumbnail Image

Bunion - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Hyperhidrosis - Pipeline Insight, 2024 - Product Thumbnail Image

Hyperhidrosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Hidradenitis - Pipeline Insight, 2024 - Product Thumbnail Image

Hidradenitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Moderate to Severe Acne - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate to Severe Acne - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 70 Pages
  • Global
From
Neuropathic Pruritus & Postburn Itch - Pipeline Insight, 2024 - Product Thumbnail Image

Neuropathic Pruritus & Postburn Itch - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Topical Skin Infection Treatment - Pipeline Insight, 2024 - Product Thumbnail Image

Topical Skin Infection Treatment - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more